4,5-Dibromo-1H-imidazole

Catalog No.: 
ACJAKX173
CAS No.: 
2302-30-9
Molecular Formula: 
C3H2Br2N2
Molecular Weight: 
225.87
4,5-Dibromo-1H-imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$53.00In stockIn stock
1g98%$127.00In stockIn stock
5g98%$379.00In stockIn stock
25g98%$1365.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,5-Dibromo-1H-imidazole
IUPAC Name4,5-dibromo-1H-imidazole
MDL No.MFCD00091826
Molecular FormulaC3H2Br2N2
Molecular Weight225.87
SMILESBrC1=C(Br)N=CN1
InChI KeyMYYYOBVDIRECDX-UHFFFAOYSA-N
Synonym4,5-Dibromo-1H-imidazole | 2302-30-9 | 4,5-Dibromoimidazole | 1H-Imidazole, 4,5-dibromo- | MFCD00091826 | BRN 0108688 | dibromoimidazole | Imidazole, 4,5-dibromo- | 1H-Imidazole,4,5-dibromo | 5-23-04-00464 (Beilstein Handbook Reference) | SCHEMBL392946 | 4,5-Dibromo-1H-imidazo
CAS No.2302-30-9
PubChem CID200605

Safety Data

Pictogram
CorrosiveToxic
Signal Word
Danger
Hazard Statement(s)
H301-H315-H318-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P310-P302+P352-P304+P340-P305+P351+P338-P310-P321-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACJAKX173 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJAKX173 route product structure diagram
    ACJAKX1732302-30-9In Stock
Inquiry

2. ACJAKX173 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJAKX173 route product structure diagram
    ACJAKX1732302-30-9In Stock
Inquiry

3. ACJAKX173 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJAKX173 route product structure diagram
    ACJAKX1732302-30-9In Stock
Inquiry

Comments (0)